Triple Positive Breast Cancers Treated with Neoadjuvant Therapy - Clinicopathologic Characteristics and Pathologic Complete Response Rate

被引:0
|
作者
Kandel, Avi [1 ]
Kombak, Faruk [1 ]
Campanella, Gabriele [1 ]
Bilal, Khawaja [2 ]
Kowtha, Lakshmi [1 ]
Collins, Victoria [1 ]
Zeizafoun, Nebras [3 ]
Henderson, Gregory [1 ]
Harigopal, Malini [1 ]
Zeng, Jennifer [1 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Mt Sinai Hlth Syst, New York, NY USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
154
引用
收藏
页码:S183 / S184
页数:2
相关论文
共 50 条
  • [1] Complete pathologic response to neoadjuvant therapy for oesophageal cancers
    Zaborowski, A.
    Heneghan, H. M.
    Granahan, A.
    King, S.
    Ravi, N.
    Reynolds, J. V.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S173 - S173
  • [2] Pathologic Complete Response and Oncologic Outcomes in Locally Advanced Breast Cancers Treated With Neoadjuvant Radiation Therapy: An Australian Perspective
    Lin, Yuan-Hong
    Chidley, Phoebe
    Admojo, Lorenztino
    Jassal, Sunil
    Zantuck, Natalie
    Foroudi, Farshad
    Bevington, Elaine
    Chew, Grace
    Hyett, Anthony
    Loh, Su Wen
    Ng, Suat Li
    Leech, Tristan
    Baker, Caroline
    Law, Michael
    Ooi, Wei Ming
    Yong, Charles
    Khor, Richard
    Chao, Michael
    PRACTICAL RADIATION ONCOLOGY, 2023, 13 (04) : 301 - 313
  • [3] Clinicopathologic Characteristics of Breast Cancer Patients Who Had a Pathologic Complete Response after Neoadjuvant Treatment
    Karahan, Furkan
    Bozok, Yeliz Yilmaz
    Gokova, Melek
    Bulut, Merve Gursoy
    Kucukzeybek, Betul Bolat
    ANNALI ITALIANI DI CHIRURGIA, 2024, 95 (06) : 1240 - 1248
  • [4] Predictors of pathologic complete response in HER2 positive breast cancer patients treated with neoadjuvant targeted therapy
    Rosario, Mariela Huerta
    Sahoo, Sunati
    CANCER RESEARCH, 2020, 80 (04)
  • [5] Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Fujii, Takeo
    Kogawa, Takahiro
    Wu, Jimin
    Sahin, Aysegul A.
    Liu, Dian D.
    Chavez-MacGregor, Mariana
    Giordano, Sharon H.
    Raghavendra, Akshara
    Murthy, Rushmy K.
    Tripathy, Debu
    Shen, Yu
    Yamal, Jose-Miguel
    Ueno, Naoto T.
    BRITISH JOURNAL OF CANCER, 2017, 116 (04) : 509 - 514
  • [6] Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Takeo Fujii
    Takahiro Kogawa
    Jimin Wu
    Aysegul A Sahin
    Dian D Liu
    Mariana Chavez-MacGregor
    Sharon H Giordano
    Akshara Raghavendra
    Rushmy K Murthy
    Debu Tripathy
    Yu Shen
    Jose-Miguel Yamal
    Naoto T Ueno
    British Journal of Cancer, 2017, 116 : 509 - 514
  • [7] Circulating lymphocytes and pathologic complete response rate among patients with early stage triple negative breast cancer treated with neoadjuvant chemotherapy
    Talamantes, S. M.
    Costa, R. L.
    Rademaker, A.
    Santa-Maria, C. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [8] Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
    Zhu, Jiujun
    Li, Jianbin
    Fan, Zhimin
    Wang, Haibo
    Zhang, Jianguo
    Yin, Yongmei
    Fu, Peifen
    Geng, Cuizhi
    Jin, Feng
    Jiang, Zefei
    Liu, Zhenzhen
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (16)
  • [9] Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’
    Kadri Altundag
    British Journal of Cancer, 2017, 116 : e10 - e10
  • [10] Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'
    Altundag, Kadri
    BRITISH JOURNAL OF CANCER, 2017, 116 (08) : e10 - e10